Cargando…
Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection
Patients with cancers have been severely affected by the COVID-19 pandemic. This is highlighted by the adverse outcomes in cancer patients with COVID-19 as well as by the impact of the COVID-19 pandemic on cancer care. Patients with cancer constitute a heterogeneous population that exhibits distinct...
Autores principales: | LATIF, MUHAMMAD BILAL, SHUKLA, SUDHANSHU, DEL RIO ESTRADA, PERLA MARIANA, RIBEIRO, SUSAN PEREIRA, SEKALY, RAFICK PIERRE, SHARMA, ASHISH ARUNKUMAR |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641406/ https://www.ncbi.nlm.nih.gov/pubmed/34871809 http://dx.doi.org/10.1016/j.trsl.2021.12.001 |
Ejemplares similares
-
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
por: Sekaly, Rafick-Pierre
Publicado: (2008) -
Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome
por: Messina, Francesco, et al.
Publicado: (2021) -
IFN-α blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health
por: Swainson, Louise A., et al.
Publicado: (2022) -
Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines
por: Pelletier, Adam N, et al.
Publicado: (2022) -
Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective
por: Aid, Malika, et al.
Publicado: (2018)